Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
GI Innovation, Inc.
Merck Sharp & Dohme LLC
K36 Therapeutics, Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
UroTrials Company (GmbH)
Xijing Hospital
Alterome Therapeutics, Inc.
Eli Lilly and Company
ViroMissile, Inc.
Pfizer
Northwestern University
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Angiex, Inc.
Ottawa Hospital Research Institute
MacroGenics
Astellas Pharma Inc
ARTBIO Inc.
University of Oklahoma
Institut Bergonié
Eli Lilly and Company
Kidney Cancer Research Bureau
IDEAYA Biosciences
HiberCell, Inc.
NRG Oncology
Memorial Sloan Kettering Cancer Center
Palo Alto Veterans Institute for Research
OncoNano Medicine, Inc.
MOMA Therapeutics
GlaxoSmithKline
Sairopa B.V.
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Centre Hospitalier Universitaire de la Guadeloupe
University of Texas Southwestern Medical Center
Massive Bio, Inc.
M.D. Anderson Cancer Center
Centre Francois Baclesse
Institut Bergonié
7 Hills Pharma, LLC
GI Innovation, Inc.
Nurix Therapeutics, Inc.